Interestingly, MYBL1 and LIMD1 were also significantly upregulated in our MYC+BCL2−BCL6+ (associated with GCB) and MYC+BCL2+BCL6− (associated with ABC) DLBCL subgroup respectively, which is in consistent with the correlations between a novel two-gene expression index, “LIMD1-MYBL1 Index”, and GCB/ABC subtypes and clinical outcome [45, 46]. Here, MYBL1 is linked to diffuse large B-cell lymphoma.